DEVON, Pa., March 05, 2020 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results